← GeneDx Holdings Corp. WGS
Market Price
$78.07
Market Cap
$2.35B
P/E Ratio
N/A
Revenue (FY 2025)
↑40.0% YoY
$427.54M
3-Yr CAGR: 22.1%
Net Income
N/A
Net Margin: N/A
Free Cash Flow
↑142.0% YoY
$14.26M
FCF Yield: 0.61%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
N/A
ROA: N/A
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (WGS)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2019 | $196.2M | — | $82.8M | — | — | — | — | $-18.7M | $-30.7M | — |
| FY 2020 | $179.3M | -8.6% | $4.0M | — | — | — | — | $-0.4M | $-24.5M | +20.1% |
| FY 2021 | $212.2M | +18.3% | $-16.6M | — | — | — | — | $-190.4M | $-199.8M | -716.3% |
| FY 2022 | $234.7M | +10.6% | $-26.8M | — | — | — | — | $-319.2M | $-326.3M | -63.3% |
| FY 2023 | $202.6M | -13.7% | $90.0M | — | — | — | — | $-180.1M | $-185.4M | +43.2% |
| FY 2024 | $305.4M | +50.8% | $194.4M | — | — | — | — | $-28.5M | $-34.0M | +81.7% |
| FY 2025 | $427.5M | +40.0% | $298.2M | — | — | — | — | $33.3M | $14.3M | +142.0% |
Valuation
Market Price
$78.07
Market Cap
$2.35B
Enterprise Value
$2.30B
P/E Ratio
N/A
P/B Ratio
7.52
FCF Yield
0.61%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
69.74%
Operating Margin
N/A
Net Margin
N/A
Return on Equity (ROE)
N/A
Return on Assets (ROA)
N/A
Asset Turnover
49.23x
Revenue 3-Yr CAGR
22.13%
Financial Health & Liquidity
Current Ratio
0.19
Cash Ratio
2.35
Debt / Equity
0.171
Debt / Assets
6.070
Cash & Equivalents
$105.00M
Total Debt
$52.72M
Book Value / Share
$10.38
Cash Flow Efficiency
Operating Cash Flow
$33.28M
Capital Expenditures (CapEx)
$19.02M
Free Cash Flow
$14.26M
OCF / Revenue
7.78%
FCF / Revenue
3.34%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$10.38
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$8.69M
Total Liabilities
$44.66M
Stockholders' Equity
$308.18M
Current Assets
$8.69M
Current Liabilities
$44.66M